retatrutide

retatrutide

7 Retatrutide Outperforms Tirzepatide - The Lie About Semaglutide

Retatrutide improves body-fat loss by about 20% more than tirzepatide in MC4R-deficient patients over 52 weeks, offering a clearer path for those who have plateaued on existing GLP-1 therapies. This finding comes from a recent head-to-head trial that measured fat loss, appetite changes, and metabolic rate. Medical Disclaimer: This article

semaglutide

When to Pick Semaglutide vs. Tirzepatide for Weight Loss

Choosing between semaglutide and tirzepatide hinges on whether you value oral convenience - semaglutide’s pill format increases adherence by about 7% - or the higher average weight loss seen with tirzepatide (≈20% versus 15% in 2023 trials). Both drugs are GLP-1 receptor agonists approved for obesity, yet their dosing